Compare Keramika Indonesia Assosiasi Tbk. (KIAS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keramika Indonesia Assosiasi Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Keramika Indonesia Assosiasi Tbk. trades at Rp21 (market cap 313.51B), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.2× Keramika Indonesia Assosiasi Tbk.'s market cap. Which is the better fit depends on your goals.
| KIAS | LABS | |
|---|---|---|
Market Cap | 313.51B | 691.25B |
Volume | — | 635.5K |
Lot | — | 6.36K |
Turnover | — | 110.15M |
Average Price | — | 173.33 |
Value | — | 110.15M |
Indicative Equilibrium Price | — | 174 |
Indicative Equilibrium Volume | — | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Keramika Indonesia Assosiasi Tbk.
KIA Group is one of the most diversified ceramic manufacturers in Indonesia, manufacturing Floor tiles (KSM), wall ties (KIA) and roof tiles (KKM). From their modest origins, a small ceramic tableware producer in the 1950s, KIA Group has to grown up to become Indonesias leading ceramic building material manufacturer. KIA Group received official recognition of its quality management system standard from SGS certification ISO 9002 no. Q4724 in 1995. In addition, KIA Group is in compliance with the World Bank Environmental and Social Policy Standard.
Read more on KIAS →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
